Skip to main content
Dezhan Healthcare Company Limited (SHE:000813)
China flag China · Delayed Price · Currency is CNY
2.800
-0.080 (-2.78%)
Nov 13, 2026, 3:04 PM CST

Dezhan Healthcare Company Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
349.22396.81466.49498.09570.86734.48
Revenue Growth
-10.34%-14.94%-6.35%-12.75%-22.28%-23.72%
Gross Profit
157.96211.23296.09274.96211.41473.06
Operating Income
-219.31-182.03-80.67-55.69-153.149.77
Net Income
-387.88-345.42-20.4183.31-46.95-57.58
Earnings Per Share
-0.18-0.16-0.010.04-0.02-0.03
EPS Growth
------

Revenue by Segment
Chart
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Pharmaceutical Business Segment
394.03463.89489.24562.19703.17
Other Business Segments
1.010.50.70.230.03
Peptides
1.772.095.884.857.09
Total
396.81466.49498.09570.86734.48

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
694.981,8162,5312,7962,9992,492
Total Debt
128.63134.7818.137.579.0712.36
Net Cash (Debt)
566.361,6812,5132,7892,9902,480
Net Cash Growth
-74.70%-33.10%-9.91%-6.73%20.58%-29.44%
Net Cash Per Share
0.270.791.171.281.351.11

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
-47.84.72-14.59127.87161.7242.41
Capital Expenditures
-221.85-235.99-166.55-159.73-67.56-126.92
Free Cash Flow
-269.65-231.27-181.14-31.8694.16-84.51
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
45.23%53.23%63.47%55.20%37.04%64.41%
Operating Margin
-62.80%-45.87%-17.29%-11.18%-26.82%6.78%
Pretax Margin
-132.02%-105.95%-9.46%16.43%-21.21%-5.05%
Profit Margin
-111.07%-87.05%-4.38%16.73%-8.22%-7.84%
FCF Margin
-77.22%-58.28%-38.83%-6.40%16.50%-11.51%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
---84.57--
Forward PE
-25.9625.9625.9625.9625.96
P/FCF Ratio
----87.40-
PS Ratio
16.8120.2914.5314.1514.4212.29